+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

EPA and DHA Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 5459022
  • Report
  • June 2022
  • Region: Global
  • 135 Pages
  • Mordor Intelligence

FEATURED COMPANIES

  • BASF SE
  • Corbion NV
  • Croda International PLC
  • KD Pharma Group
  • Koninklijke DSM NV
  • Novasep Holding SAS
The EPA and DHA market (henceforth referred to as the market studied) was valued at USD 1,626.10 million in 2021, and it is projected to reach USD 2,372.90 million in 2027, registering a CAGR of 6.76% during the forecast period 2022-2027.

The pandemic has affected the entire food system and has laid bare its fragility. Border closures, trade restrictions, and confinement measures prevented EPA and DHA manufacturers from accessing markets, including for buying inputs and selling their produce, thus disrupting domestic and international food supply chains. However, despite disruptions in the supply chain, the COVID-19 pandemic strongly accelerated the global demand for bioactive ingredients, including EPA and DHA, in the wake of growing consumer demand for fortified food and beverages as well as dietary supplements.

Globally, EPA and DHA have been gaining importance and are becoming a part of consumers’ daily diets. The key reasons for this change are primarily the increased prevalence of lifestyle diseases and people taking preventive healthcare measures. Moreover, the emerging applications of EPA and DHA in food, dietary supplements, and clinical nutrition have further stimulated the market’s growth.

New sources of EPA and DHA have been gaining prominence recently. Microalgae, a source rich in omega-3 and beta-carotene, has gained immense popularity among manufacturers as a sustainable source of food and fuel. Algae omega ingredients play a key role in driving the overall market due to the growing demand for algae omega in infant food fortification, as they provide benefits similar to that of fish oil but have no off-putting odor or taste. Also, omega ingredients obtained from algae are considered more bioavailable and sustainable for production.

In 2017, a new European project, VALUEMAG (Valuable Products From Algae Using New Cultivation and Extraction Techniques), was announced to improve the overall extraction techniques for microalgae cultivation. The project is made up of 11 research centers across nine countries, including Greece, Spain, the Netherlands, the United Kingdom, Austria, France, Cyprus, Slovakia, and Italy.

Key Market Trends


Increasing Application of Docosahexaenoic Acid (DHA)


The DHA segment is majorly driven by its growing demand and incorporation in infant formulae and nutritional products targeting children's health, as it is an essential building block for the growth and maturation of an infant's brain and retina. It is mostly obtained from fish and algae oils. Additionally, it is extensively used in fortified foods and dietary supplements, where it is majorly used for treating Type 2 diabetes, coronary artery disease (CAD), dementia, and attention deficit hyperactivity disorder (ADHD). The healthy aging-related benefits of DHA have also led to its successful utilization in geriatric nutrition products. Furthermore, an increasing number of product launches worldwide favors the industry’s growth. For instance, Organic Technologies, in 2017, launched two new DHA omega-3 concentrates to its line of AlaskOmega fish oils and concentrates - a high DHA concentrate and a medium strength DHA (non-tuna) tuna oil alternative.



Asia-Pacific Holds a Significant Share in the EPA and DHA Market


Asia-Pacific has been leading the market studied, owing to the high consolidated production and consumption in countries like China and Japan. Consumers in this region tend to source omega-3 majorly from fish-rich diets rather than algae-based products. Thus, food manufacturers do not find it worth increasing the production cost by incorporating expensive algal omega-3 ingredients as a replacement for fish extracted ingredients. Moreover, to cater to the demand for DHA and EPA ingredients in India, in September 2021, the Indian Food Safety Authority gave Evonik clearance to import and distribute AvailOm in India to accelerate the roll-out of its omega-3 solution.

There has also been a growing demand among children to fulfill their key nutritional requirements due to the increasing awareness about the crucial role of EPA and DHA on brain development and other vital functions. To cater to the demand, major market players are introducing new product innovations to maintain the necessary nutritional intake of the young ones.

For instance, in October 2021, Danone India, with its mission ‘to bring health through food,’ launched fortified beverages AptaGrow for children. AptaGrow includes prebiotic and DHA for the physical and cognitive development of children.



Competitive Landscape


In 2021, the EPA and DHA market was moderately concentrated by a few players, such as BASF SE, Croda International PLC, and Koninklijke DSM NV. Many small companies started commercial production of EPA and DHA only to be acquired by larger players as a competitive strategy by major companies that are also focussing on investment in research and development to compete in the growing market. Moreover, during the last few years, various global companies have become active in the EPA and DHA market with tactical acquisitions, mergers, and partnerships.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BASF SE
  • Corbion NV
  • Croda International PLC
  • KD Pharma Group
  • Koninklijke DSM NV
  • Novasep Holding SAS

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Eicosapentaenoic Acid (EPA)
5.1.2 Docosahexaenoic Acid (DHA)
5.2 By Source
5.2.1 Fish Oil
5.2.2 Algae Oil
5.2.3 Krill Oil
5.2.4 Other Sources
5.3 By Application
5.3.1 Infant Formulae
5.3.2 Dietary Supplements
5.3.3 Fortified Food and Beverages
5.3.4 Pharmaceuticals
5.3.5 Other Applications
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Rest of North America
5.4.2 Europe
5.4.2.1 Spain
5.4.2.2 United Kingdom
5.4.2.3 Germany
5.4.2.4 France
5.4.2.5 Italy
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 Rest of Asia-Pacific
5.4.4 Rest of the World
5.4.4.1 South America
5.4.4.2 Middle-East and Africa
6 COMPETITIVE LANDSCAPE
6.1 Market Share Analysis
6.2 Strategies Adopted by Players
6.3 Most Active Companies
6.4 Company Profiles
6.4.1 Koninklijke DSM NV
6.4.2 KD Pharma Group
6.4.3 The Archer Daniels Midland Company
6.4.4 Corbion NV
6.4.5 Novasep Holding SAS
6.4.6 Neptune Wellness Solutions
6.4.7 BASF SE
6.4.8 Omega Protein Corporation
6.4.9 Croda International PLC
6.4.10 Novotech Nutraceuticals
6.4.11 Polaris SA
7 MARKET OPPORTUNITIES AND FUTURE TRENDS8 IMPACT OF COVID-19 ON THE MARKET
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Koninklijke DSM NV
  • KD Pharma Group
  • The Archer Daniels Midland Company
  • Corbion NV
  • Novasep Holding SAS
  • Neptune Wellness Solutions
  • BASF SE
  • Omega Protein Corporation
  • Croda International PLC
  • Novotech Nutraceuticals
  • Polaris SA
Note: Product cover images may vary from those shown

Loading
LOADING...